Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer
出版年份 2017 全文链接
标题
Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer
作者
关键词
Drug therapy, Cancer stem cells, Polymerase chain reaction, Cancer chemotherapy, Cancer treatment, Cytotoxicity, Islands, MTS assay
出版物
PLoS One
Volume 12, Issue 2, Pages e0171044
出版商
Public Library of Science (PLoS)
发表日期
2017-02-15
DOI
10.1371/journal.pone.0171044
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Low-dose cisplatin-induced CXCR4 expression promotes proliferation of ovarian cancer stem-like cells
- (2016) Yifei Chen et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy
- (2016) Hyun-Kyung Jung et al. JOURNAL OF CONTROLLED RELEASE
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system
- (2015) R. Chiaramonte et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
- (2015) Giovanni Luca Gravina et al. PROSTATE
- Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
- (2015) Aaron Goldman et al. Nature Communications
- Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
- (2015) Yan Gao et al. Oncotarget
- CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
- (2015) Haixia Long et al. Oncotarget
- Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
- (2015) Wenzhe Ma et al. Scientific Reports
- Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
- (2015) Michele Cioffi et al. Scientific Reports
- Lymph Node Stromal Cells Enhance Drug-Resistant Colon Cancer Cell Tumor Formation through SDF-1α/CXCR4 Paracrine Signaling
- (2015) David A. Margolin et al. NEOPLASIA
- Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer
- (2014) Jia Li et al. BMB Reports
- Anticancer Effects of Chemokine Receptor 4(CXCR4) Gene Silenced by CXCR4-siRNA in Nude Mice Model of Ovarian Cancer
- (2014) Wei Liu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Xuqi Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Novel Role for NFAT3 in ERK-Mediated Regulation of CXCR4
- (2014) Keven Huang et al. PLoS One
- Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells
- (2014) Zhi-hua Yu et al. TUMOR BIOLOGY
- CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype
- (2013) Kyu Sub Kang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer
- (2013) Baoyao Xue et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis
- (2013) Ai-Fang Huang et al. Molecular Cancer
- Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy
- (2013) Emma Salomonnson et al. PLoS One
- The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
- (2012) A Popple et al. BRITISH JOURNAL OF CANCER
- SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
- (2012) Xuqi Li et al. CANCER LETTERS
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin
- (2011) Francesca Casagrande et al. CANCER
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
- (2011) Miranda Ween et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of CD44 as a Surface Biomarker for Drug Resistance by Surface Proteome Signature Technology
- (2011) J. W. Cain et al. MOLECULAR CANCER RESEARCH
- CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
- (2010) S Singh et al. BRITISH JOURNAL OF CANCER
- Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
- (2010) Lyndsay V. Rhodes et al. CANCER RESEARCH
- Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line
- (2010) M. F. Shi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12
- (2010) Raphael Lis et al. INTERNATIONAL JOURNAL OF CANCER
- An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
- (2009) J. Kwong et al. MOLECULAR CANCER THERAPEUTICS
- CXCR4 and CXCL12 down-regulation: A novel mechanism for the chemoprotection of 3,3′-diindolylmethane for breast and ovarian cancers
- (2008) Erin L. Hsu et al. CANCER LETTERS
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started